INTECH Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
162,292
-572
-0.4% -$39K 0.12% 142
2026
Q1
$10.5M Sell
162,864
-34,362
-17% -$2.42M 0.1% 169
2025
Q4
$13.3M Buy
197,226
+48,559
+33% +$3.27M 0.12% 140
2025
Q3
$10.9M Buy
148,667
+46,850
+46% +$3.11M 0.1% 176
2025
Q2
$5.3M Sell
101,817
-51,382
-34% -$2.92M 0.05% 333
2025
Q1
$9.78M Buy
153,199
+13,789
+10% +$801K 0.1% 168
2024
Q4
$6.67M Buy
139,410
+83,105
+148% +$4.26M 0.06% 253
2024
Q3
$3.22M Buy
56,305
+33,542
+147% +$1.92M 0.04% 357
2024
Q2
$1.19M Buy
+22,763
New +$998K 0.01% 583

Other funds holding HALO

INTECH Investment Management's HALO Position: Q2 2026 in Review

INTECH Investment Management reduced its Halozyme (HALO) stake by 0.35% in Q2 2026, selling an estimated $39K and leaving 162,292 shares worth $12.7M. The position accounts for 0.12% of the portfolio, ranked #142.

INTECH Investment Management first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.3M in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • INTECH Investment Management held 162,292 shares of Halozyme worth $12.7M as of Q2 2026.
  • INTECH Investment Management sold 572 Halozyme shares in Q2 2026, an estimated $39K.
  • Halozyme made up 0.12% of INTECH Investment Management's portfolio in Q2 2026, its #142 holding.
  • INTECH Investment Management first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
  • INTECH Investment Management's Halozyme position peaked at $13.3M in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.